178
Participants
Start Date
February 28, 2009
Primary Completion Date
April 30, 2010
Study Completion Date
April 30, 2010
Dexlansoprazole MR QD
Dexlansoprazole MR 30 mg, capsules and dexlansoprazole MR placebo-matching capsules, orally, each once daily for up to 6 weeks.
Hueytown
Chandler
Sierra Vista
Tucson
Sherman
Sherwood
Carmichael
Garden Grove
Laguna Hills
Long Beach
Paramount
Rancho Cucamonga
Roseville
Sacramento
San Diego
San Ramon
Tustin
Westlake Village
Bristol
Boynton Beach
Hialeah
New Smyrna Beach
Winter Haven
Augusta
Conyers
Newnan
Stockbridge
Rockford
Metairie
Prince Frederick
Stevensville
Olive Branch
Egg Harbor
Albuquerque
Rochester
Wilmington
Columbus
Oklahoma City
Yukon
Portland
Lansdale
Salisbury
Chattanooga
Johnson City
Nashville
Dallas
El Paso
Houston
South Ogden
Chesapeake
Norfolk
Lakewood
Lead Sponsor
Takeda
INDUSTRY